U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. Square Vape Labs Inc. - 613512 - 07/09/2021
  1. Warning Letters

CLOSEOUT LETTER

Square Vape Labs Inc. MARCS-CMS 613512 —

Delivery Method:
VIA Electronic Mail
Reference #:
RW2101516
Product:
Tobacco
Recipient:
Recipient Name
Anthony Napolitano
Square Vape Labs Inc.

United States

admin@squarevapelabs.com
info@squarevapelabs.com
Issuing Office:
Center for Tobacco Products

United States

Dear Anthony Napolitano:

The United States Food and Drug Administration’s (FDA) Center for Tobacco Products has completed an evaluation of your corrective actions included in your email dated March 6, 2021 in response to our Warning Letter dated February 26, 2021. Based on our evaluation, it appears that you have taken steps to address the violations contained in the Warning Letter regarding your website https://squarevapelabs.com.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to ensure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. This letter also will not preclude any regulatory action should violations be observed in the future.

Sincerely,
/S/
Mallory Johnson
Branch Chief
Division of Promotion, Advertising, and Labeling
Office of Compliance and Enforcement
Center for Tobacco Products

VIA Electronic Mail

cc:

Domains By Proxy, LLC
squarevapelabs@domainsbyproxy.com

GoDaddy.com, LLC
abuse@godaddy.com

Back to Top